MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-13-2025
DURECT Corporation Shares 2011-2026 | DRRX
Annual Shares DURECT Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.3 M | 22.8 M | 22.5 M | 19.9 M | 178 M | 160 M | 145 M | 133 M | 119 M | 112 M | 103 M | 88.4 M | 87.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 178 M | 19.9 M | 93.6 M |
Quarterly Shares DURECT Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 M | 31 M | 31 M | 31 M | 30.6 M | 27.2 M | 24.5 M | 23.8 M | - | 22.8 M | 22.8 M | 22.8 M | 228 M | 227 M | 227 M | 218 M | 204 M | 202 M | 197 M | 196 M | 195 M | 192 M | 164 M | 162 M | 162 M | 162 M | 162 M | 154 M | 151 M | 147 M | 143 M | 142 M | 141 M | 138 M | 133 M | 122 M | 122 M | 120 M | 119 M | 114 M | 114 M | 112 M | 111 M | 110 M | 110 M | 102 M | 102 M | 102 M | 102 M | 87.7 M | 87.6 M | 87.5 M | 87.5 K | 87.4 M | 87.4 M | 87.3 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 228 M | 87.5 K | 117 M |
Shares of other stocks in the Drug manufacturers industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Zynerba Pharmaceuticals
ZYNE
|
42.7 M | - | - | $ 55.5 M |  USA |
 |
Alimera Sciences
ALIM
|
25.6 M | - | - | $ 142 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
150 M | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
46.3 M | - | - | $ 754 M | USA |
 |
Canopy Growth Corporation
CGC
|
108 M | $ 1.17 | -1.3 % | $ 126 M |  Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
25.8 M | - | 7.5 % | $ 6.35 M | USA |
 |
Cronos Group
CRON
|
350 M | $ 2.68 | -0.93 % | $ 1.41 B | Canada |
 |
Agile Therapeutics
AGRX
|
2.16 M | - | 10.11 % | $ 58.2 M | USA |
 |
Catalent
CTLT
|
181 M | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
12.9 M | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
235 M | - | - | $ 28.9 M |  Irlanda |
 |
Calliditas Therapeutics AB (publ)
CALT
|
50.8 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
Evoke Pharma
EVOK
|
3.34 M | - | - | $ 36.6 M | USA |
 |
HEXO Corp.
HEXO
|
127 M | - | 2.45 % | $ 38.1 M | Canada |
 |
Emergent BioSolutions
EBS
|
51.2 M | $ 12.87 | 3.04 % | $ 659 M | USA |
 |
Athenex
ATNX
|
6.54 M | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
95.1 M | $ 21.5 | -0.12 % | $ 2.05 B |  France |
 |
Evolus
EOLS
|
62 M | $ 6.16 | -8.33 % | $ 382 M | USA |
 |
Harrow Health
HROW
|
32.6 M | $ 52.73 | 5.65 % | $ 1.72 B | USA |
 |
Jupiter Wellness
JUPW
|
54.4 M | - | - | $ 33.6 M | USA |
 |
China Pharma Holdings
CPHI
|
17.5 M | $ 1.22 | 0.83 % | $ 21.3 M |  China |
 |
OrganiGram Holdings
OGI
|
256 M | $ 1.7 | -2.02 % | $ 402 M | Canada |
 |
Bausch Health Companies
BHC
|
365 M | $ 7.43 | 3.05 % | $ 2.71 B | Canada |
 |
Lannett Company
LCI
|
40.4 M | - | 1.15 % | $ 7.11 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
492 K | - | - | $ 193 M | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
14.1 M | $ 4.02 | 1.01 % | $ 56.5 M | USA |
 |
Organogenesis Holdings
ORGO
|
132 M | $ 4.34 | -6.36 % | $ 571 M | USA |
 |
Sundial Growers
SNDL
|
1.86 M | $ 1.71 | -2.01 % | $ 3.37 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
1.24 M | $ 3.83 | 5.27 % | $ 4.75 M | USA |
 |
Pacira BioSciences
PCRX
|
46.2 M | $ 25.49 | 4.19 % | $ 1.18 B | USA |
 |
Aurora Cannabis
ACB
|
169 M | $ 4.25 | -2.19 % | $ 86.3 M | Canada |
 |
Rockwell Medical
RMTI
|
23.3 M | $ 0.97 | 12.89 % | $ 22.6 M | USA |
 |
PetIQ
PETQ
|
29.1 M | - | 1.64 % | $ 400 M | USA |
 |
Perrigo Company plc
PRGO
|
137 M | $ 14.41 | 3.74 % | $ 1.98 B | USA |
 |
ProPhase Labs
PRPH
|
15.8 M | - | - | $ 5.07 M | USA |
 |
Veru
VERU
|
135 M | $ 2.29 | 0.66 % | $ 309 M | USA |
 |
Radius Health
RDUS
|
47.2 M | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
95.2 M | - | -4.76 % | $ 65.3 M | USA |
 |
cbdMD
YCBD
|
4.31 M | $ 1.01 | -12.93 % | $ 4.36 M | USA |
 |
Relmada Therapeutics
RLMD
|
30.1 M | $ 4.09 | -6.52 % | $ 123 M | USA |
 |
OptiNose
OPTN
|
112 M | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
71 M | $ 9.32 | 1.97 % | $ 662 M | USA |
 |
PLx Pharma
PLXP
|
23.7 M | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
40.8 M | $ 5.36 | -1.74 % | $ 219 M | USA |
 |
SCYNEXIS
SCYX
|
47.9 M | $ 0.64 | -0.45 % | $ 30.6 M | USA |
 |
Tricida
TCDA
|
51.3 M | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
618 M | $ 9.4 | -3.34 % | $ 5.81 B | Canada |
 |
TherapeuticsMD
TXMD
|
10.4 M | $ 1.79 | 8.18 % | $ 18.7 M | USA |
 |
Zomedica Corp.
ZOM
|
980 M | - | -0.21 % | $ 98 M | USA |